Extracted from this filing and checked against the source text.
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
Apyx Medical Corp shareholders approved Ratification of RSM US LLP as independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-08-10 meeting.
- Proposal
- auditor ratification
- Outcome
- passed
- Meeting
- 2023-08-10
Exact text from the filing
Proposal 2: The Company’s stockholders ratified the appointment of RSM US LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023 by the following vote: Number of Votes Cast in Favor Number of Votes Cast Against Number of Votes Abstained 24,542,917 26,534 53,343
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
Apyx Medical Corp shareholders approved Election of eight directors at the 2023-08-10 meeting.
- Proposal
- director election
- Outcome
- passed
- Meeting
- 2023-08-10
Exact text from the filing
On August 10, 2023, the following proposals were submitted to the stockholders of Apyx Medical Corporation (the “Company”) at its annual meeting of stockholders: (1) the election of eight (8) directors; (2) the ratification of RSM US LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2023; and (3) the approval of the Company’s 2023 Share Incentive Plan.
View on SEC.gov
Shareholder Votes
SEC 8-K Item 5.07
confidence 1.0
Apyx Medical Corp shareholders approved Approval of the 2023 Share Incentive Plan at the 2023-08-10 meeting.
- Proposal
- equity plan
- Outcome
- passed
- Meeting
- 2023-08-10
Exact text from the filing
Proposal 3: The Company’s stockholders approved the Company’s 2023 Share Incentive Plan by the following vote: Number of Votes Cast in Favor Number of Votes Cast Against Number of Votes Abstained 15,970,459 1,405,162 1,613,512
View on SEC.gov